Bernhard Fleckenstein Selected Research

Neoplasms (Cancer)

1/2022	Alternative NF-κB Signaling Discriminates Induction of the Tumor Marker Fascin by the Viral Oncoproteins Tax-1 and Tax-2 of Human T-Cell Leukemia Viruses.
10/2020	A novel positive feedback-loop between the HTLV-1 oncoprotein Tax and NF-κB activity in T-cells.
1/2020	Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy.
7/2014	The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
3/2011	The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals.
1/2008	The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernhard Fleckenstein Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 01/2008
5	Lymphoma (Lymphomas) 01/2018 - 05/2005
5	Infections 01/2018 - 08/2005
3	T-Cell Leukemia (Leukemia, T Cell) 01/2022 - 09/2014
3	Autoimmune Lymphoproliferative Syndrome 01/2018 - 12/2014
3	Carcinogenesis 06/2012 - 03/2006
2	Tyrosine Kinase 2 Deficiency 10/2022 - 09/2015
2	Virus Diseases (Viral Diseases) 10/2022 - 09/2015
2	Inflammation (Inflammations) 01/2021 - 03/2006
2	Brain Neoplasms (Brain Tumor) 01/2020 - 12/2016
2	Viremia 01/2020 - 12/2016
2	Brain Diseases (Brain Disorder) 01/2020 - 12/2016
2	Candidiasis (Moniliasis) 12/2018 - 09/2015
2	Lymphadenopathy 01/2018 - 09/2015
2	Reinfection 01/2018 - 01/2018
2	Job Syndrome (Hyper-IgE Syndrome) 09/2015 - 05/2014
2	Neoplasm Metastasis (Metastasis) 07/2014 - 03/2011
2	HIV Infections (HIV Infection) 01/2013 - 08/2005
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 03/2011 - 09/2010
1	Eosinophilia 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Astrocytoma (Pilocytic Astrocytoma) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2018
1	Tuberculosis (Tuberculoses) 12/2018
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2018
1	Anemia 01/2018
1	Otitis 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Disease Progression 12/2016
1	Glioma (Gliomas) 12/2016
1	Fanconi Anemia (Fanconi's Anemia) 10/2016
1	Atopic Dermatitis (Atopic Eczema) 09/2015
1	Abscess 09/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2015
1	Hepatomegaly 09/2015
1	Cytopenia 09/2015
1	Splenomegaly 09/2015
1	Focal Cortical Dysplasia 02/2015
1	Drug Resistant Epilepsy 02/2015
1	Mycoses (Diseases, Fungus) 05/2014
1	Eczema 05/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2010
1	Primary Effusion Lymphoma 01/2008

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2005
6	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 05/2005
4	Interleukin-12 (IL 12)IBA 10/2022 - 09/2015
4	Interleukin-23 (Interleukin 23)IBA 10/2022 - 09/2015
4	Trans-Activators (Trans-Acting Factor)IBA 12/2021 - 09/2010
3	fascinIBA 01/2022 - 03/2011
3	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 03/2011
3	Immunoglobulin E (IgE)IBA 01/2018 - 05/2014
2	CytokinesIBA 01/2021 - 12/2018
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2018 - 09/2015
2	Interleukin-10 (Interleukin 10)IBA 09/2015 - 09/2015
2	Death Domain ReceptorsIBA 09/2015 - 12/2014
2	Fas Ligand Protein (Fas Ligand)IBA 09/2015 - 12/2014
2	LigandsIBA 12/2014 - 06/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2012 - 05/2005
1	Interleukin-13IBA 01/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	2,6-dinitrotoluene (DNT)IBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2016
1	Immunoglobulin G (IgG)IBA 12/2016
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	TOR Serine-Threonine KinasesIBA 02/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2015
1	CD4 Antigens (CD4 Antigen)IBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	AntibodiesIBA 06/2012
1	Biomarkers (Surrogate Marker)IBA 03/2011
1	viral interferon regulatory factorsIBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 03/2006
1	ChemokinesIBA 08/2005
1	Glycoproteins (Glycoprotein)IBA 08/2005
1	AntigensIBA 08/2005

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2010
2	Radiotherapy 01/2020 - 12/2016
1	Chemoradiotherapy 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Aftercare (After-Treatment) 12/2016